Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of 331.06 billion. The enterprise value is 342.99 billion.
Market Cap | 331.06B |
Enterprise Value | 342.99B |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Current Share Class | 3.36B |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.61% |
Shares Change (QoQ) | -0.20% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.18B |
Valuation Ratios
The trailing PE ratio is 21.84 and the forward PE ratio is 17.66.
PE Ratio | 21.84 |
Forward PE | 17.66 |
PS Ratio | 7.54 |
PB Ratio | 16.49 |
P/TBV Ratio | 78.35 |
P/FCF Ratio | 28.87 |
P/OCF Ratio | 17.41 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.15, with an EV/FCF ratio of 29.91.
EV / Earnings | 22.63 |
EV / Sales | 7.32 |
EV / EBITDA | 14.15 |
EV / EBIT | 15.12 |
EV / FCF | 29.91 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.86.
Current Ratio | 0.74 |
Quick Ratio | 0.54 |
Debt / Equity | 0.86 |
Debt / EBITDA | 0.76 |
Debt / FCF | 1.50 |
Interest Coverage | 41.95 |
Financial Efficiency
Return on equity (ROE) is 88.12% and return on invested capital (ROIC) is 47.91%.
Return on Equity (ROE) | 88.12% |
Return on Assets (ROA) | 23.29% |
Return on Invested Capital (ROIC) | 47.91% |
Return on Capital Employed (ROCE) | 58.02% |
Revenue Per Employee | 567,426 |
Profits Per Employee | 195,821 |
Employee Count | 77,349 |
Asset Turnover | 0.77 |
Inventory Turnover | 1.22 |
Taxes
In the past 12 months, Novo Nordisk has paid 4.01 billion in taxes.
Income Tax | 4.01B |
Effective Tax Rate | 20.93% |
Stock Price Statistics
The stock price has decreased by -53.18% in the last 52 weeks. The beta is 0.22, so Novo Nordisk's price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | -53.18% |
50-Day Moving Average | 68.38 |
200-Day Moving Average | 89.68 |
Relative Strength Index (RSI) | 43.16 |
Average Volume (20 Days) | 137,700 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of 43.92 billion and earned 15.16 billion in profits. Earnings per share was 3.40.
Revenue | 43.92B |
Gross Profit | 37.18B |
Operating Income | 21.27B |
Pretax Income | 19.17B |
Net Income | 15.16B |
EBITDA | 22.50B |
EBIT | 21.27B |
Earnings Per Share (EPS) | 3.40 |
Balance Sheet
The company has 6.02 billion in cash and 17.20 billion in debt, giving a net cash position of -11.18 billion.
Cash & Cash Equivalents | 6.02B |
Total Debt | 17.20B |
Net Cash | -11.18B |
Net Cash Per Share | n/a |
Equity (Book Value) | 20.07B |
Book Value Per Share | 4.52 |
Working Capital | -8.94B |
Cash Flow
In the last 12 months, operating cash flow was 19.02 billion and capital expenditures -7.55 billion, giving a free cash flow of 11.47 billion.
Operating Cash Flow | 19.02B |
Capital Expenditures | -7.55B |
Free Cash Flow | 11.47B |
FCF Per Share | n/a |
Margins
Gross margin is 84.65%, with operating and profit margins of 48.43% and 34.51%.
Gross Margin | 84.65% |
Operating Margin | 48.43% |
Pretax Margin | 43.65% |
Profit Margin | 34.51% |
EBITDA Margin | 51.23% |
EBIT Margin | 48.43% |
FCF Margin | 26.10% |
Dividends & Yields
This stock pays an annual dividend of 1.66, which amounts to a dividend yield of 2.43%.
Dividend Per Share | 1.66 |
Dividend Yield | 2.43% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 48.61% |
Buyback Yield | 0.61% |
Shareholder Yield | 3.04% |
Earnings Yield | 4.58% |
FCF Yield | 3.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
Last Split Date | Sep 13, 2023 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 7.88 and a Piotroski F-Score of 5.
Altman Z-Score | 7.88 |
Piotroski F-Score | 5 |